TH75729A - Chemical compound - Google Patents
Chemical compoundInfo
- Publication number
- TH75729A TH75729A TH501001774A TH0501001774A TH75729A TH 75729 A TH75729 A TH 75729A TH 501001774 A TH501001774 A TH 501001774A TH 0501001774 A TH0501001774 A TH 0501001774A TH 75729 A TH75729 A TH 75729A
- Authority
- TH
- Thailand
- Prior art keywords
- alkyl
- substances
- chemical compound
- replaced
- chemical formula
- Prior art date
Links
Abstract
DC60 (18/07/48) สารประกอบสูตร (I) (สูตรเคมี) (I) สารผสมซึ่งประกอบด้วยสารเหล่านั้น, กรรมวิธีสำหรับเตรียมสารเหล่านั้น และการใช้สารเหล่านั้น ในการรักษาทางการแพทย์ (ตัวอย่างเช่น ดัดแปรความว่องไวของ CCR5 รีเซพเตอร์ในสัตว์เลี้ยงลูก ด้วยนม) สารประกอบสูตร (I) (สูตรเคมี) (I) สารผสมซึ่งประกอบด้วยสารเหล่านั้น, กรรมวิธีสำหรับเตรียมสารเหล่านั้น และการใช้สารเหล่านั้น ในการรักษาทางการแพทย์ (ตัวอย่างเช่น ดัดแปรความว่องไวของ CCR5 รีเซพเตอร์ในสัตว์เลี้ยงลูก ด้วยนม) สิทธิบัตรยาDC60 (18/07/48) Formula compound (I) (chemical formula) (I) A mixture consisting of such substances, a process for preparing such substances, and a use of such substances in the treatment of medicine (for example, modifying the activity of the CCR5 receptor in mammals). Formula compound (I) (chemical formula) (I) A mixture consisting of such substances, a process for preparing such substances, and a use of such substances in the treatment of medicine (for example, modifying the activity of the CCR5 receptor in mammals). Pharmaceutical patents.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH75729A true TH75729A (en) | 2006-02-16 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR078522A1 (en) | SPIROPIPERIDINE COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE TO PREPARE A USEFUL MEDICINAL PRODUCT TO TREAT DIABETES AND INTERMEDIARY COMPOUND FOR SYNTHESIS | |
| EA200600527A1 (en) | PPAR ACTIVATING COMPOUND AND CONTAINING ITS PHARMACEUTICAL COMPOSITION | |
| EA200971143A1 (en) | BENZAMIDE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS FOR THEIR RECEIVING AND APPLICATION | |
| NO20081367L (en) | Phenyl and pyridyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals | |
| EA201001595A1 (en) | COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS | |
| RU2011149256A (en) | PESTICIDAL COMPOSITIONS | |
| UA109774C2 (en) | CRYSTAL FORMS OF SAXAGLIPTIN AND ITS PROCESS (OPTIONS) | |
| NZ602754A (en) | Substituted 1,3-benzothiazepines useful in treating metabolic disorders | |
| RU2008142535A (en) | DERIVATIVES OF AZOLOPYRIDIN-3-ONA AS ENDOTHELIAL LIPASE INHIBITORS | |
| EP1807412A1 (en) | Cyclic diarly ureas suitable as tyrosine kinase inhibitors | |
| EA201001344A1 (en) | NITROGEN-CONTAINING BICYCLIC COMPOUNDS, ACTIVE IN THE CONDITIONS OF CHRONIC PAIN | |
| AR068045A1 (en) | CATECOLAMINE DERIVATIVES AND DRUGS OF THE SAME | |
| RU2009140761A (en) | Derivatives of the amide of imidazolidine carboxylic acid as lipase and phospholipase inhibitors | |
| NO20076425L (en) | Methods of Treating Drug-Resistant Cancer | |
| MA29653B1 (en) | NOVEL CAMPTOTHECIN ANALOG COMPOUNDS, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| TN2010000173A1 (en) | CGRP ANTAGONISTS | |
| AR072876A1 (en) | DERIVATIVES OF 4,5-DIHIDRO-OXAZOL-2-ILO, MEDICINES CONTAINING THEM, METHOD OF PREPARATION AND USE OF THE SAME FOR THE TREATMENT OF NERVOUS SYSTEM DISEASES, AMONG OTHER. | |
| BR112014004275A2 (en) | isoxazoline derivatives as insecticide compounds | |
| AR043430A1 (en) | DERIVATIVES OF DIARILCICLOALQUILO, PROCESSES FOR ITS PREPARATION AND ITS USE AS PHARMACEUTICAL AGENTS | |
| ATE500752T1 (en) | USE OF SPHINGOLIPIDS IN THE TREATMENT AND PREVENTION OF TYPE 2 DIABETES MELLITUS, INSULIN RESISTANCE AND METABOLISM SYNDROME | |
| TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
| TH75729A (en) | Chemical compound | |
| TW200833696A (en) | Spiro-piperidine derivatives | |
| TH84722A (en) | Chemical compound | |
| TH106304A (en) | The derivative (ethylamine) ethyl propaname is a beta2 long-acting agonist. |